Clinical Trial Update: ELN 2022 in MENAFC ( Middle Eastern or North Coast of Africa ) Patients With Newly AML

View source ↗

Summary

ClinicalTrials.gov entry describing a trial of the ELN 2022 risk-stratification approach in patients with newly diagnosed acute myeloid leukemia from the MENAFC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Leukemia, Myeloid | Status: NOT_YET_RECRUITING